Glucose Monitoring Devices Market Size, Share and Forecast 2032

Glucose Monitoring Devices market size was valued at USD 13,154 million in 2024 and is projected to reach USD 20,080.85 million by 2032.

By End User (Hospitals and clinics, Homecare settings); By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); By Technology (Invasive monitoring, Non-invasive monitoring); By Product Type (Self-monitoring blood glucose devices, Continuous glucose monitoring devices)

SKU: CR4678Report Pages: 250Category: HealthcareReport Format: PDF, ExcelLast Updated: May 28Author: Dr. Pankaj SharmaReviewed by: Deepti AgrawalPreferred on

Market Report Metrics

Revenue, 2024 -
USD 13,154 million
Forecast Year -
2032
CAGR (2024–2032)
5.43%
Report Coverage
Global

Glucose Monitoring Devices Market Overview:

The glucose monitoring devices market was valued at USD 13,154 million in 2024. The market is projected to reach USD 20,080.85 million by 2032. Growth is expected at a CAGR of 5.43% during the forecast period.

REPORT ATTRIBUTE DETAILS
Historical Period 2020-2023
Base Year 2024
Forecast Period 2025-2032
Glucose Monitoring Devices Market Size 2024 USD 13,154 million
Glucose Monitoring Devices Market, CAGR 5.43%
Glucose Monitoring Devices Market Size 2032 USD 20,080.85 million

Glucose Monitoring Devices Market Insights

  • Rising diabetes prevalence, aging populations, and emphasis on regular self-monitoring fuel glucose monitoring devices market growth worldwide.
  • Self-monitoring blood glucose devices lead with a 58% segment share, supported by affordability, ease of use, and wide availability.
  • Competition centers on accuracy, sensor longevity, mobile connectivity, and reimbursement access, while cost pressures restrain premium adoption.
  • North America leads with a 37% regional share, followed by Europe at 29% and Asia Pacific at 24%, reflecting healthcare access, guideline-driven testing, and growing homecare monitoring.
Glucose Monitoring Devices Market Size

Glucose Monitoring Devices Market Segmentation Analysis:

By Product Type

Self-monitoring blood glucose devices lead the glucose monitoring devices market with a 58% segment share. Widespread availability and affordability support strong adoption. Patients rely on fingerstick testing for routine glucose checks. Clinical familiarity strengthens physician recommendations. Insurance coverage supports consistent usage. Continuous glucose monitoring devices hold a 42% share, driven by real-time tracking and improved glycemic control. SMBG devices dominate due to lower costs and ease of access. High diabetes prevalence sustains daily testing needs. Ongoing device accuracy improvements further support SMBG demand across home and clinical settings.

  • For instance, Roche Diagnostics’ Accu-Chek Guide system delivers laboratory-aligned accuracy within ±10 mg/dL at low glucose ranges, based on ISO 15197:2013 standards.
 

By Technology

Invasive monitoring dominates with a 73% market share in the glucose monitoring devices market. Proven accuracy and regulatory approval support strong trust. Fingerstick and sensor-based methods remain clinical standards. Non-invasive monitoring accounts for a 27% share, driven by patient comfort and reduced pain. Technology maturity limits large-scale adoption for non-invasive options. Invasive dominance reflects reliability and established reimbursement. Healthcare providers prioritize precise readings for treatment decisions. Continuous improvements in sensor comfort and lifespan further reinforce invasive monitoring leadership.

  • For instance, Dexcom’s G7 CGM system uses a 10-day wearable sensor with an automated applicator that inserts the filament in under one second, improving placement consistency and user comfort.

By End User

Homecare settings represent the largest end-user segment with a 61% market share. Rising self-management of diabetes supports home use. User-friendly devices enable frequent monitoring. Growing elderly population increases homecare reliance. Hospitals and clinics hold a 39% share, driven by diagnosis and treatment initiation. Homecare dominance reflects shift toward patient-centered care. Telehealth integration supports remote monitoring. Convenience and cost savings strengthen adoption in home environments. Long-term disease management trends continue driving demand in homecare settings.

Key Growth Drivers

Rising Global Prevalence of Diabetes

Diabetes prevalence continues increasing across all age groups. Lifestyle changes and aging populations raise disease incidence. Regular glucose monitoring remains essential for disease management. Physicians emphasize frequent testing to prevent complications. Homecare adoption supports daily monitoring routines. Early diagnosis increases device usage rates. Public health programs promote screening initiatives. Urbanization influences dietary habits and diabetes risk. This driver sustains consistent demand for glucose monitoring devices across developed and emerging healthcare systems.

  • For instance, Abbott Laboratories reports that its FreeStyle Libre systems generate one glucose reading every minute, producing 1,440 readings per day per user, supporting tighter glycemic tracking.

Shift Toward Self-Monitoring and Homecare Management

Patients increasingly manage diabetes at home. User-friendly devices simplify daily glucose tracking. Homecare reduces hospital visits and treatment costs. Telehealth integration supports remote data sharing. Elderly patients benefit from convenient monitoring solutions. Caregivers rely on easy-to-use devices. Insurance coverage supports home-based testing. Patient education improves compliance. This driver accelerates demand for personal glucose monitoring devices globally.

  • For instance, Roche Diagnostics’ Accu-Chek Instant meter delivers test results in under 4 seconds and stores up to 720 readings with date and time stamps, improving long-term monitoring continuity.

Technological Advancements in Monitoring Accuracy

Device accuracy improves with sensor innovation. Enhanced calibration reduces measurement errors. Faster result delivery supports timely treatment decisions. Continuous monitoring improves glycemic control. Data connectivity enables trend analysis. Software integration supports personalized care plans. Manufacturers invest in R&D continuously. Improved reliability builds patient and physician trust. This driver strengthens adoption across both clinical and homecare environments.

Growth of Continuous Glucose Monitoring Adoption

Continuous monitoring gains acceptance among patients. Real-time alerts improve safety and compliance. Reduced fingerstick testing enhances comfort. Integration with mobile apps improves usability. Physicians value continuous data insights. Pediatric and insulin-dependent patients show strong adoption. Technology upgrades extend sensor life. This trend creates strong opportunities for premium device expansion.

  • For instance, Dexcom’s G7 system captures glucose readings every 5 minutes, generating 288 data points per day to support detailed glycemic profiling.

Integration with Digital Health Platforms

Devices connect seamlessly with smartphones and wearables. Cloud-based data sharing supports remote care. AI-driven analytics enhance glucose insights. Digital dashboards improve patient engagement. Healthcare providers access real-time data. Personalized alerts support lifestyle adjustments. This trend opens opportunities for data-driven diabetes management solutions.

  • For instance, Medtronic’s Guardian Connect platform uploads glucose data automatically to CareLink software, enabling clinicians to review up to 30 days of continuous readings per patient session.

Key Challenges

High Cost of Advanced Monitoring Devices

Advanced devices carry higher upfront costs. Limited reimbursement affects accessibility. Cost sensitivity remains high in emerging markets. Sensor replacement adds recurring expenses. Budget constraints limit adoption. Pricing pressure affects manufacturer margins. This challenge slows penetration of premium glucose monitoring technologies.

Accuracy and Reliability Concerns in New Technologies

New monitoring methods face validation challenges. Inconsistent readings reduce user confidence. Environmental factors affect performance. Regulatory approval timelines remain lengthy. Clinical acceptance requires extensive testing. Device calibration increases complexity. This challenge delays adoption of next-generation monitoring solutions.

Regional Analysis

North America

North America holds a 37% market share in the glucose monitoring devices market. High diabetes prevalence drives routine monitoring demand. Strong insurance coverage supports device access. Continuous glucose monitoring adoption remains high among insulin users. Digital health integration improves care coordination. Homecare monitoring dominates usage patterns. Robust regulatory frameworks ensure device reliability. Innovation pipelines remain active across leading manufacturers. The United States leads regional demand due to advanced healthcare infrastructure and strong patient education programs.

Europe

Europe accounts for a 29% market share in the glucose monitoring devices market. Public healthcare systems support broad access to monitoring tools. Aging populations increase diabetes management needs. Clinical guidelines promote regular testing. Continuous monitoring grows steadily through reimbursement expansion. Pharmacies and clinics serve as key distribution points. Regulatory emphasis ensures quality and safety. Western Europe drives volume through established care pathways and technology adoption.

Asia Pacific

Asia Pacific represents a 24% market share in the glucose monitoring devices market. Rapid urbanization raises diabetes incidence. Large patient populations drive volume demand. Homecare adoption grows with awareness programs. Cost-effective SMBG devices dominate usage. Digital platforms expand access and education. Government initiatives improve screening rates. China and India contribute significantly due to scale and improving healthcare access.

Rest of the World

The rest of the world holds a 10% market share in the glucose monitoring devices market. Latin America and the Middle East lead regional demand. Public health initiatives support screening and monitoring. Price sensitivity influences device choice. SMBG remains the primary method. Distribution improves through pharmacies and clinics. Gradual reimbursement expansion supports adoption. Growth opportunities rise as awareness and access improve.

Glucose Monitoring Devices Market Segmentations:

By Product Type

  • Self-monitoring blood glucose devices
  • Continuous glucose monitoring devices

By Technology

  • Invasive monitoring
  • Non-invasive monitoring

By End User

  • Hospitals and clinics
  • Homecare settings

 By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Competitive Landscape

Competitive landscape analysis highlights Abbott Laboratories, Dexcom, Medtronic, Roche Diagnostics, and Ascensia Diabetes Care as leading participants in the glucose monitoring devices market. These companies compete through technology innovation, product accuracy, and strong global distribution. Market leaders focus on continuous glucose monitoring systems with real-time alerts and data connectivity. Integration with mobile apps and digital health platforms strengthens differentiation. Established players leverage reimbursement coverage and clinician trust to defend market share. Ongoing investment in sensor longevity and user comfort improves adoption. Strategic partnerships with digital health providers expand ecosystem capabilities. Competitive pressure remains high as companies balance affordability with advanced features. Regulatory compliance, data reliability, and patient outcomes remain critical factors shaping competitive positioning across global markets.

 

Key Player Analysis

  • Abbott Laboratories
  • Dexcom
  • Medtronic
  • Roche Diagnostics
  • Ascensia Diabetes Care
  • LifeScan
  • Senseonics
  • Ypsomed
  • Braun
  • ARKRAY

 Recent Developments

  • In April 2025, Dexcom received U.S. FDA clearance for the Dexcom G7 15-Day Continuous Glucose Monitoring (CGM) System.
  • In 2024, Roche Diagnostics maintained efforts to enhance connected glucose monitoring, continuing integration of blood glucose data with digital management platforms and apps.

Report Coverage

The research report offers an in-depth analysis based on Product Type, Technology, End User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Glucose Monitoring Devices Market Size, Share and Forecast 2032
Report Attribute Details
Details
Historical Period
-
Base Year
2024
Forecast Period
2024–2032
Glucose Monitoring Devices Size 2024
USD 13,154 million
Glucose Monitoring Devices CAGR
5.43%
Glucose Monitoring Devices Size 2032
USD 20,080.85 million

Request a Free Sample

Fill in your details and we'll send you a free sample report.

  • Sample data tables & charts
  • Research methodology

Market Dynamics

Rising Global Prevalence of Diabetes

Increasing rates of diabetes across all age groups, driven by lifestyle changes and aging populations, are fueling the need for regular glucose monitoring. This sustains consistent demand for both self-monitoring and continuous glucose monitoring devices worldwide.

Shift Toward Self-Monitoring and Homecare Management

Patients are increasingly managing diabetes at home, supported by user-friendly devices and telehealth integration. This trend reduces hospital visits, lowers treatment costs, and drives strong adoption of home-based glucose monitoring solutions.

Technological Advancements in Monitoring Accuracy

Continuous innovation in sensor technology and device calibration is improving the accuracy and reliability of glucose monitoring devices. Enhanced data connectivity and integration with digital health platforms are further supporting adoption among both patients and healthcare providers.

Expansion of Insurance Coverage and Reimbursement

Broader insurance coverage and reimbursement policies, especially in developed markets, are making advanced glucose monitoring devices more accessible. This supports higher adoption rates and encourages regular monitoring among patients.

Integration with Digital Health Platforms

The ability of glucose monitoring devices to connect with smartphones, wearables, and cloud-based platforms enables real-time data sharing and analytics. This integration enhances patient engagement, supports remote care, and opens new opportunities for data-driven diabetes management.

Need a Custom Version of This Report?

Tailor the scope, geography, or segments to your exact requirements.

  • Custom geography or segment scope
  • Direct access to our analyst team

Frequently Asked Questions

What is the current market size for Glucose Monitoring Devices market, and what is its projected size in 2032?
The Glucose Monitoring Devices market size was USD 13,154 million in 2024 and is projected to reach USD 20,080.85 million by 2032.
At what Compound Annual Growth Rate is the Glucose Monitoring Devices market projected to grow between 2024 and 2032?
The Glucose Monitoring Devices market is projected to grow at a CAGR of 5.43% during the forecast period.
Which Glucose Monitoring Devices market segment held the largest share in 2024?
Self-monitoring blood glucose devices held the largest share in the Glucose Monitoring Devices market in 2024.
What are the primary factors fueling the growth of the Glucose Monitoring Devices market?
Rising diabetes prevalence, homecare adoption, and routine self-monitoring drive Glucose Monitoring Devices market growth.
Who are the leading companies in the Glucose Monitoring Devices market?
Leading Glucose Monitoring Devices market companies include Abbott Laboratories, Dexcom, Medtronic, Roche Diagnostics, and Ascensia Diabetes Care.
Which region commanded the largest share of the Glucose Monitoring Devices market in 2024?
North America commanded the largest share of the Glucose Monitoring Devices market in 2024 with a 37% market share.

Table of Content

Chapter 1 Market Segmentation

  • 1.1 Segmentation Framework
    • 1.1.1 Product and Service Classification
    • 1.1.2 Application and End-Use Classification
    • 1.1.3 Technology and Solution Classification
    • 1.1.4 Customer and Distribution Channel Classification
    • 1.1.5 Geographic Segmentation
    • 1.1.6 Market Segment Definitions and Boundaries
  • 1.2 By End User
    • 1.2.1 Hospitals and clinics
    • 1.2.2 Homecare settings
  • 1.3 By Technology
    • 1.3.1 Invasive monitoring
    • 1.3.2 Non-invasive monitoring
  • 1.4 By Product Type
    • 1.4.1 Self-monitoring blood glucose devices
    • 1.4.2 Continuous glucose monitoring devices

Chapter 2 Introduction

  • 2.1 Report Objectives and Scope
  • 2.2 Product Definition and Industry Terminology
  • 2.3 Market Inclusions and Exclusions
  • 2.4 Research Process
    • 2.4.1 Primary Research and Expert Interviews
    • 2.4.2 Secondary Research and Source Review
    • 2.4.3 Top-Down and Bottom-Up Estimation
    • 2.4.4 Data Triangulation and Verification
  • 2.5 Market Size Measurement Basis
    • 2.5.1 2024: USD 13,154 million → 2032: USD 20,080.85 million
  • 2.6 Historical and Forecast Reference Periods
    • 2.6.1 Base Year: 2024
    • 2.6.2 Forecast Period: 2024-2032
  • 2.7 Research Assumptions and Limitations

Chapter 3 Executive Summary

  • 3.1 Market Snapshot and Key Findings
  • 3.2 Base-Year Market Size, 2024
  • 3.3 Forecast Market Size, 2032
  • 3.4 Revenue and Volume Growth Outlook
  • 3.5 Key Demand and Supply Indicators
  • 3.6 Leading Market Segments
  • 3.7 Fastest-Growing Market Opportunities
  • 3.8 Regional Performance Highlights
  • 3.9 Technology and Industry Transformation
  • 3.10 Competitive Landscape Summary
  • 3.11 Analyst View and Strategic Implications

Chapter 4 Global Glucose Monitoring Devices Market Trends and Developments

  • 4.1 Historical Industry Development
  • 4.2 Recent Market Trends and Developments
  • 4.3 Demand and Customer Behavior Trends
  • 4.4 Technology and Product Innovation
  • 4.5 Artificial Intelligence, Automation and Digitalization
  • 4.6 Local Manufacturing and Supply Chain Realignment
  • 4.7 Industry Partnerships, Mergers and Acquisitions
  • 4.8 Sustainability and Circular Economy Developments
  • 4.9 Government and Private Sector Investment Trends
  • 4.10 Emerging Business Models and Commercialization
  • 4.11 Industry Developments and Announcements

Chapter 5 Global Glucose Monitoring Devices Market Production, Supply and Demand Analysis

  • 5.1 Demand Trend and Consumption Analysis
  • 5.2 Demand Forecast, 2024-2032
  • 5.3 Production and Output Trend
  • 5.4 Production and Output Forecast, 2024-2032
  • 5.5 Installed Capacity and Capacity Utilization
  • 5.6 Company-Wise Production Plants and Statistics
    • 5.6.1 Installed Production Capacity
    • 5.6.2 Actual Production
    • 5.6.3 Planned Capacity and Expansion Targets
  • 5.7 Supply Chain Structure and Procurement Trends
  • 5.8 Supply-Demand Gap and Bottlenecks
  • 5.9 Import Dependence and Sourcing Structure
  • 5.10 Contract Manufacturing and Outsourcing
  • 5.11 Regional Supply and Demand Concentration

Chapter 6 Global Glucose Monitoring Devices Market Pricing Analysis

  • 6.1 Pricing Structure and Measurement
  • 6.2 Historical Pricing Trends
  • 6.3 Pricing Outlook, 2024-2032
  • 6.4 Average Selling Price and Unit Economics
  • 6.5 Pricing by Product and Market Segment
  • 6.6 Geographic Pricing Differences
  • 6.7 Key Input, Energy, Labor and Logistics Costs
  • 6.8 Contract Pricing and Purchasing Models
  • 6.9 Pricing Sensitivity and Competitive Positioning
  • 6.10 Price, Margin and Profitability Implications

Chapter 7 Global Glucose Monitoring Devices Market Dynamics

  • 7.1 Market Growth Drivers
    • 7.1.1 Demand-Side Drivers
    • 7.1.2 Technology and Innovation Drivers
    • 7.1.3 Infrastructure and Investment Drivers
    • 7.1.4 Regulatory and Policy Drivers
  • 7.2 Market Restraints
    • 7.2.1 Cost and Affordability Constraints
    • 7.2.2 Technology and Adoption Barriers
    • 7.2.3 Supply Chain and Operational Constraints
  • 7.3 Market Challenges
    • 7.3.1 Competitive Pressure and Margin Erosion
    • 7.3.2 Skills, Infrastructure and Implementation Gaps
  • 7.4 Emerging Market Opportunities
  • 7.5 Market Dynamics Impact and Time-Horizon Assessment

Chapter 8 Global Glucose Monitoring Devices Value Chain Analysis

  • 8.1 Industry Value Chain Overview
  • 8.2 Upstream Suppliers and Critical Inputs
  • 8.3 Technology and Component Providers
  • 8.4 Manufacturing or Service Delivery
  • 8.5 Distribution, Channel Partners and Integrators
  • 8.6 Downstream Applications and End Users
  • 8.7 Value Addition and Profit Pools
  • 8.8 Vertical Integration and Outsourcing
  • 8.9 Supplier Concentration and Risk
  • 8.10 Supply Chain Localization and Resilience

Chapter 9 Global Glucose Monitoring Devices Market Regulations and Policies

  • 9.1 Relevant Laws, Standards and Compliance Frameworks
  • 9.2 Product, Service, Safety and Quality Requirements
  • 9.3 Government Policies, Incentives and Subsidies
  • 9.4 Imports, Exports and Trade Barriers
  • 9.5 Public Procurement and Local Content Requirements
  • 9.6 Environmental and Sustainability Compliance
  • 9.7 Upcoming Policy Changes and Market Implications

Chapter 10 Global Glucose Monitoring Devices Market Hotspots and Opportunities

  • 10.1 Market Opportunity Mapping and Growth Hotspots
  • 10.2 High-Growth Applications and Customer Groups
  • 10.3 Underserved Markets and White-Space Opportunities
  • 10.4 Emerging Technology and Product Opportunities
  • 10.5 New Capacity and Investment Hotspots
  • 10.6 Market Entry and Expansion Opportunities
  • 10.7 Distribution and Partnership Opportunities
  • 10.8 Near-Term and Long-Term Commercial Potential
  • 10.9 Opportunity Attractiveness and Execution Risks

Chapter 11 Global Glucose Monitoring Devices Market Outlook, 2024-2032

  • 11.1 Market Size and Analysis
    • 11.1.1 Revenue (Market Measurement: 2024: USD 13,154 million → 2032: USD 20,080.85 million)
    • 11.1.2 Market Volume and Quantity Sold
    • 11.1.3 Historical Market Size
    • 11.1.4 Base-Year Market Size, 2024
  • 11.2 Market Forecast, 2024-2032
    • 11.2.1 Revenue Forecast to 2032
    • 11.2.2 Volume Forecast to 2032
    • 11.2.3 CAGR and Year-on-Year Growth
    • 11.2.4 Incremental Revenue Opportunity
  • 11.3 Forecast Assumptions and Scenario Analysis
    • 11.3.1 Base-Case Forecast
    • 11.3.2 Optimistic and Conservative Scenarios
    • 11.3.3 Technology, Pricing and Policy Sensitivities
  • 11.4 Market Attractiveness and Growth Outlook

Chapter 12 Global Glucose Monitoring Devices Market Segmentation and Outlook

  • 12.1 Segmentation Summary and Market Shares, 2024
  • 12.2 Largest and Fastest-Growing Segments
  • 12.3 By End User - Market Size and Forecast, 2024-2032
    • 12.3.1 Segment Definition and Scope
    • 12.3.2 Historical Market Size
    • 12.3.3 Revenue Forecast, 2024-2032
    • 12.3.4 Volume Forecast, 2024-2032
    • 12.3.5 Base-Year Market Share, 2024
    • 12.3.6 Segment CAGR and Growth Drivers
    • 12.3.7 Subsegment Market Size and Forecast
      • 12.3.7.1 Hospitals and clinics
      • 12.3.7.2 Homecare settings
    • 12.3.8 Subsegment Pricing and Adoption Trends
    • 12.3.9 Leading Suppliers and Competition
    • 12.3.10 Regional Demand and Opportunities
  • 12.4 By Technology - Market Size and Forecast, 2024-2032
    • 12.4.1 Segment Definition and Scope
    • 12.4.2 Historical Market Size
    • 12.4.3 Revenue Forecast, 2024-2032
    • 12.4.4 Volume Forecast, 2024-2032
    • 12.4.5 Base-Year Market Share, 2024
    • 12.4.6 Segment CAGR and Growth Drivers
    • 12.4.7 Subsegment Market Size and Forecast
      • 12.4.7.1 Invasive monitoring
      • 12.4.7.2 Non-invasive monitoring
    • 12.4.8 Subsegment Pricing and Adoption Trends
    • 12.4.9 Leading Suppliers and Competition
    • 12.4.10 Regional Demand and Opportunities
  • 12.5 By Product Type - Market Size and Forecast, 2024-2032
    • 12.5.1 Segment Definition and Scope
    • 12.5.2 Historical Market Size
    • 12.5.3 Revenue Forecast, 2024-2032
    • 12.5.4 Volume Forecast, 2024-2032
    • 12.5.5 Base-Year Market Share, 2024
    • 12.5.6 Segment CAGR and Growth Drivers
    • 12.5.7 Subsegment Market Size and Forecast
      • 12.5.7.1 Self-monitoring blood glucose devices
      • 12.5.7.2 Continuous glucose monitoring devices
    • 12.5.8 Subsegment Pricing and Adoption Trends
    • 12.5.9 Leading Suppliers and Competition
    • 12.5.10 Regional Demand and Opportunities
  • 12.6 Segment Growth Comparison
  • 12.7 Segment Attractiveness and Priority Matrix

Chapter 13 Global Glucose Monitoring Devices End-Use and Application Market Outlook

  • 13.1 End-Use Industry and Customer Demand Structure
  • 13.2 Leading Applications and Customer Groups
  • 13.3 End-Use Market Size, Share and Forecast
  • 13.4 Major End-Use Industry Deep Dives
    • 13.4.1 Customer Requirements and Use Cases
    • 13.4.2 Demand and Replacement Cycles
    • 13.4.3 Technical and Regulatory Considerations
    • 13.4.4 Purchasing and Procurement Models
    • 13.4.5 Leading Vendors and Distribution Channels
    • 13.4.6 Forecast and Commercial Opportunities
  • 13.5 Emerging Applications and Cross-Segment Demand
  • 13.6 End-Use Industry Investment Priorities

Chapter 14 Global Glucose Monitoring Devices Geographic Market Outlook, 2024-2032

  • 14.1 Regional Market Size and Share, 2024
  • 14.2 Regional Market Forecast, 2024-2032
  • 14.3 Regional Pricing, Production and Demand Differences
  • 14.4 North America
    • 14.4.1 United States
    • 14.4.2 Canada
    • 14.4.3 Mexico
  • 14.5 Europe
    • 14.5.1 Germany
    • 14.5.2 France
    • 14.5.3 Italy
    • 14.5.4 United Kingdom
    • 14.5.5 Spain
    • 14.5.6 Poland
    • 14.5.7 Russia
    • 14.5.8 Netherlands
    • 14.5.9 Belgium
    • 14.5.10 Sweden
    • 14.5.11 Denmark
    • 14.5.12 Norway
    • 14.5.13 Rest of Europe
  • 14.6 Asia Pacific
    • 14.6.1 China
    • 14.6.2 India
    • 14.6.3 Japan
    • 14.6.4 South Korea
    • 14.6.5 Thailand
    • 14.6.6 Indonesia
    • 14.6.7 Vietnam
    • 14.6.8 Malaysia
    • 14.6.9 Australia
    • 14.6.10 Rest of Asia Pacific
  • 14.7 Latin America
    • 14.7.1 Brazil
    • 14.7.2 Argentina
    • 14.7.3 Colombia
    • 14.7.4 Chile
    • 14.7.5 Rest of Latin America
  • 14.8 Middle East
    • 14.8.1 Saudi Arabia
    • 14.8.2 United Arab Emirates
    • 14.8.3 Turkey
    • 14.8.4 Israel
    • 14.8.5 Iran
    • 14.8.6 Rest of the Middle East
  • 14.9 Africa
    • 14.9.1 South Africa
    • 14.9.2 Egypt
    • 14.9.3 Nigeria
    • 14.9.4 Morocco
    • 14.9.5 Rest of Africa
  • 14.10 Regional Investment, Policy and Supply Chain Differences
  • 14.11 Regional Competitive Landscape
  • 14.12 Geographic Growth Hotspots

Chapter 15 Global Glucose Monitoring Devices Technology, Innovation and Sustainability Outlook

  • 15.1 Technology Landscape and Maturity
  • 15.2 Product, Process and Service Innovation
  • 15.3 AI, Automation and Digital Tools in the Industry
  • 15.4 Technology Adoption and Performance Benchmarking
  • 15.5 Innovation Pipeline and R&D Investment
  • 15.6 Patent and Intellectual Property Trends
  • 15.7 Energy Efficiency and Resource Management
  • 15.8 Sustainability, Recycling and Circularity
  • 15.9 Technology Roadmap, 2024-2032
  • 15.10 Risks of Obsolescence and Technology Substitution

Chapter 16 Global Glucose Monitoring Devices Market Key Strategic Imperatives

  • 16.1 Growth and Market Entry Priorities
  • 16.2 High-Return Products and Segments
  • 16.3 Pricing, Profitability and Cost Optimization
  • 16.4 Technology Investment and Product Differentiation
  • 16.5 Supply Chain Localization and Resilience
  • 16.6 Distribution and Customer Acquisition
  • 16.7 Partnership, Acquisition and Capacity Strategy
  • 16.8 Regional Expansion Priorities
  • 16.9 Short-, Medium- and Long-Term Actions

Chapter 17 Competition Outlook

  • 17.1 Industry Competition Characteristics
  • 17.2 Market Structure and Concentration
  • 17.3 Market Share and Competitive Positioning, 2024
  • 17.4 Company-Wise Revenue and Product Benchmarking
  • 17.5 Production and Service Capacity Benchmarking
  • 17.6 Technology, Pricing and Differentiation
  • 17.7 Regional Footprint and Distribution Strength
  • 17.8 Mergers, Acquisitions and Strategic Alliances
  • 17.9 New Entrants and Competitive Threats
  • 17.10 Porter's Five Forces and Industry Attractiveness
  • 17.11 Competitive Outlook, 2024-2032

Chapter 18 Company Profiles

  • 18.1 Company Coverage and Selection Criteria
  • 18.2 Abbott Laboratories
    • 18.2.1 Business Description
    • 18.2.2 Company Ownership and Geographic Presence
    • 18.2.3 Product and Service Portfolio
    • 18.2.4 Manufacturing and Operating Footprint
    • 18.2.5 Production Capacity and Expansion Plans
    • 18.2.6 Financial Performance and Investment
    • 18.2.7 Market Share and Competitive Position
    • 18.2.8 Technology and Innovation Capabilities
    • 18.2.9 Strategic Alliances or Partnerships
    • 18.2.10 Recent Developments
    • 18.2.11 Growth Strategy and Outlook
  • 18.3 Dexcom
  • 18.4 Medtronic
  • 18.5 Roche Diagnostics
  • 18.6 Ascensia Diabetes Care
  • 18.7 LifeScan
  • 18.8 Senseonics
  • 18.9 Ypsomed
  • 18.10 Braun
  • 18.11 ARKRAY
  • 18.12 Other Relevant Market Participants

Note: Every listed company is profiled on the structure shown under the first company. The company list is preliminary and may change based on research findings, market developments, data availability and client requirements.

Chapter 19 Disclaimer

  • 19.1 Research and Forecast Disclaimer
  • 19.2 Data Source and Estimation Limitations

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.

Methodology

Meet the Team

Dr. Pankaj Sharma
Dr. Pankaj Sharma

Healthcare Domain Expert & Medical Advisor

Dr. Pankaj Sharma is an anesthesiologist and healthcare strategic advisor who reviews epidemiological models, therapeutic market assessments and clinical assumptions at Credence Research Inc, so that quantitative forecasts reflect clinical realities.

Deepti Agrawal

Reviewed by

Deepti Agrawal

Head of Editorial Operations

Related Topics

Pharmaceutical Logistics Market Size, Share, Growth and Forecast, 2025-2035

Pharmaceutical logistics market worth USD 108.00 billion in 2025 is set to reach USD 240.83 billion by 2035, rising at an 8.35% CAGR on biologics and trade.

North America Retail Pharmacy Market Size, Share, Growth and Forecast, 2025-2035

North America retail pharmacy market worth USD 562.72 billion in 2025 is set to reach USD 821.03 billion by 2035 at a 3.85% CAGR as prescriptions rise

PD-1 and PD-L1 Inhibitors Market Size, Share, Growth and Forecast, 2025-2035

PD-1 and PD-L1 inhibitors market worth USD 62.01 billion in 2025 is forecast to reach USD 98.62 billion by 2035, at a 4.75% CAGR as early-stage use widens.

Radiopharmaceutical Theranostics Market Size, Share, Growth and Forecast, 2025-2035

Radiopharmaceutical theranostics market grows from USD 5.58 billion in 2025 to USD 17.18 billion by 2035 at an 11.90% CAGR as PSMA therapy moves earlier.

Contract Research Organization Services (CROS) Market Size, Share, Growth and Forecast, 2025-2035

Contract research organization services market worth USD 74.60 billion in 2025 reaches USD 149.52 billion by 2035, at a 7.20% CAGR as bookings recover.

Latin American Cardiovascular Devices Market Size, Share, Growth and Forecast, 2025-2035

Latin American cardiovascular devices market worth USD 3.90 billion in 2025 will reach USD 6.98 billion by 2035 at a 6.00% CAGR as PFA and cath labs spread.